![Tencent soars on DeepSeek integration into Weixin](https://i-invdn-com.investing.com/news/LYNXNPED4H22G_S.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.140 | 3.140 | 0.000 |
Stocks | 96.860 | 96.860 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 13.809 | 13.782 |
Price to Book | 2.224 | 2.048 |
Price to Sales | 1.292 | 1.302 |
Price to Cash Flow | 10.056 | 9.509 |
Dividend Yield | 3.084 | 3.103 |
5 Years Earnings Growth | 9.615 | 10.189 |
Name | Net % | Category Average |
---|---|---|
Industrials | 22.030 | 20.188 |
Technology | 14.540 | 7.250 |
Financial Services | 14.430 | 17.460 |
Consumer Cyclical | 13.720 | 14.039 |
Healthcare | 9.940 | 9.576 |
Consumer Defensive | 9.030 | 11.819 |
Communication Services | 7.310 | 7.091 |
Energy | 6.830 | 6.705 |
Real Estate | 2.170 | 3.116 |
Number of long holdings: 54
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Relx | GB00B2B0DG97 | 3.68 | 4,073.00 | -1.50% | |
Unilever | GB00B10RZP78 | 3.57 | 52.86 | -1.82% | |
Shell | GB00BP6MXD84 | 3.55 | 32.22 | +0.81% | |
AstraZeneca | GB0009895292 | 3.53 | 11,708.0 | -2.14% | |
Compass | GB00BD6K4575 | 3.39 | 2,836.00 | +0.28% | |
TP ICAP | JE00BMDZN391 | 3.11 | 261.00 | -0.19% | |
BP | GB0007980591 | 3.06 | 467.80 | +0.84% | |
GlobalData | GB00BR3VDF43 | 2.98 | 195.00 | -0.51% | |
GSK plc | GB00BN7SWP63 | 2.77 | 1,435.00 | -0.66% | |
Gamma Communications PLC | GB00BQS10J50 | 2.69 | 1,362.00 | -1.30% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Liontrust GF Special Situations FC1 | 2.53M | 2.47 | 0.48 | 6.19 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review